Fat Grafting Technique, A Paradigm Shift in the Treatment of Tuberous Breast

Authors

  • Joan Fontdevila Hospital Clinic of Barcelona. University of Barcelona, Barcelona, Spain
  • Omar Weshahy Hospital Clinic of Barcelona. University of Barcelona, Barcelona, Spain
Abstract:

BACKGROUND The tuberous breast syndrome is a condition that affects young women and can bring on serious disorders of self-esteem. There are numerous surgical techniques to correct this condition, but most of them include the use of breast implants to replace lack of volume. Nowadays, patients are increasingly becoming more demanding to get a definitive solution with minimal aesthetic sequelae. METHODS We present a series of 11 patients with tuberous breast deformities treated with lipofilling technique. Fat harvest was performed by conventional lipoaspiration with 3 mm cannulas, centrifuged at 2000 rpm for 2 minutes and injected in the breast were was needed with 1.9 mm blunt cannulas. RESULTS The patient’s average age was 24 year old with a BMI of 23.4 kg/m2. Volumes between 80 and 250 ml per breast were injected in every session, requiring a total volume of 413 ml per breast. Most patients required up to two procedures to achieve the complete breast correction. The mean follow-up was 29.7 months. All patients had good aesthetics results with minimal complications. CONCLUSION Natural breast mound with excellent cosmetic result can be achieved with fat grafting. Fat grafting main advantage is to respond to physiological changes in weight over time. In addition, lipofilling do not carry the inherent complications of implants. We strongly believe it is a safe and easy technique to reproduce in properly selected patients and with minimal morbidity it can cause the best natural result.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Tuberous breast correction by fat grafting.

INTRODUCTION Tuberous breast is a rare malformation that has negative physical and psychological impacts during puberty. A range of surgical techniques has been used to correct breast shape and volume in this context, including a combination of skin plasty and mammary gland remodeling, as well as prostheses and locoregional flaps. The authors have used fat grafting as a complementary technique ...

full text

Autologous Fat Transplantation – A Paradigm Shift in Breast Reconstruction

Fat grafting to the breast is not a new concept. It has been under consideration since the 19th century when pioneers attempted inserting bulk volumes of fat (Neuber, 1893, Czerny 1895). Interest in fat grafting was rekindled with the introduction of liposuction, which provided an easy and reliable source of fat. After a brief pause in evolution of breast fat grafting due to concerns over confo...

full text

Treatment of Vitiligo with Blister Grafting Technique

Background: Surgical treatments of vitiligo are punch grafting, blister grafting, flip-top transplantation, split skin grafting, etc aiming at rebuilding of melanocytic population in those patients who do not respond to medical treatment . The objective of this study was determination of efficacy of blister grafting technique in the treatment of vitiligo. Methods: This study was done on 10 pati...

full text

Fat Grafting Breast Augmentation Mammaplasty

DESCRIPTION A middle-aged woman presented to the plastic surgery clinic for breast augmentation. Fat grafting augmentation mammaplasty was performed successfully.

full text

Breast Thermal Imaging, The Paradigm Shift

Infrared thermal imaging of the breast, a non-invasive adjunctive diagnostic methodology has become all but non-existent in the United States. This is in large part due to extensive debate concerning thermography in the trial courts, related to spinal injury cases and also due to the model or basis used for breast thermal imaging. This paper attempts to identify possible factors which will brin...

full text

Paradigm-HF: a Paradigm Shift in Heart Failure Treatment?

DOI: 10.5935/abc.20160009 In the first semester of this year, the U.S. Food and Drug Administration (FDA) approved a new drug for the treatment of heart failure, LCZ696, commercially known as Entresto. This new treatment option was evaluated by the FDA on a priority basis (fast track designation), which allowed a faster release than usual. In Brazil, the drug is being evaluated by the National ...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 7  issue None

pages  72- 77

publication date 2018-01

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023